Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Lifestyle Drugs Market Outlook: Key Indications, Epidemiology, and Emergent Drugs' returned 5 results - Page 1 of 1   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom The Drug-Eluting Stent Market Outlook to 2016   Business Insights, March 2011, Pages: 115 on the future DES market. - Identify key innovations that will shape the DES market of the future. - Gain insight into the influence of the emerging economies in determining the present and future DES Antiageing and Life Enhancement Pharmacotherapeutics: Rejuvenating Drug Markets To 2012 and Beyond   Spectra Intelligence, Jan 2006, Pages: 580 ? - What is the future outlook for marketed antiageing and lifestyle drugs and for those in development? - What is the prediction for the global markets by 2020? - What are the top prospects The Global Image Dermatology Drug Market, 2005-2012: High-Growth Opportunities in Aesthetic Medicine   Spectra Intelligence, Nov 2005, Pages: 158 proceedings - Medical/pharma associations REPORT HIGHLIGHTS AND KEY FINDINGS - Dermatological drugs indicated for image dermatology account for a market valued at US$1.8 billion, which is predicted to increase UAE Healthcare Sector Forecast to 2012   RNCOS E-Services Private Limited, Nov 2011, Pages: 95 Demographics 3.2 Epidemiological Backdrop 3.2.1 Diabetes 3.2.2 Hypertension 3.2.3 Cancer 3.2.4 Infectious Diseases 3.3 Health Insurance 4. Emerging Market Trends 4.1 Investments in Healthcare 4 Breast Cancer Therapeutics - Global Strategic Business Report   Global Industry Analysts, Inc., Oct 2006, Pages: 563 The Biochemical Process of Sex hormones II-35 What are the Drug Categories? II-35 Categories of Hormonal Agents II-35 Hormonal Therapies and their Indications II-36 An Analysis of Hormonal Drug Classes II-36 Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network